Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP)

Last updated: November 25, 2021
Sponsor: Ramsay Générale de Santé
Overall Status: Active - Recruiting

Phase

N/A

Condition

Amyloidosis

Treatment

N/A

Clinical Study ID

NCT05150353
2018-A00881-54 Promoteur
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study is based on the hypothesis that MRI could make it possible to non-invasively detect these amyloid deposits at the level of the wrist using parametric sequences known as T1 mapping, in the form of an extension of T1 in the wrists. areas where amyloid deposits are found in the wrist.

Eligibility Criteria

Inclusion

Inclusion Criteria: Patient group:

  • Woman or man over 18 years old
  • With ATTR or AL cardiac amyloidosis with or without carpal tunnel. The diagnosis ofamyloidosis must be proven by a positive myocardial biopsy or diphosphonatescintigraphy.
  • Affiliate or beneficiarie of a social security scheme.
  • Having signed the free and informed consent. Healthy volunteers:
  • Woman or man over 18 years old
  • Affiliate or beneficiarie of a social security scheme.
  • Having signed the free and informed consent.

Exclusion

Exclusion Criteria: Patient group:

  • Patients participating in another clinical study.
  • Patients suffering from rheumatoid arthritis or other autoimmune disease (vasculitis,lupus, scleroderma, etc.)
  • Patients with a medical history of wrist surgery (exclude the operated side).
  • Patients with a contraindication to performing an MRI (pacemaker, etc.)
  • Pregnant or breastfeeding women.
  • Protected patients: Adults under guardianship, curatorship or other legal protection,deprived of their liberty by judicial or administrative decision. Healthy volunteer:
  • Volunteers participating in another clinical study.
  • Volunteers suffering from rheumatoid arthritis or other autoimmune disease (vasculitis, lupus, scleroderma, etc.)
  • Pregnant or breastfeeding women.
  • Volunteer with a contraindication to performing an MRI (pacemaker, etc.)
  • Protected volunteers: Adults under guardianship, guardianship or other legalprotection, deprived of their liberty by judicial or administrative decision.

Study Design

Total Participants: 140
Study Start date:
January 24, 2020
Estimated Completion Date:
April 24, 2022

Connect with a study center

  • Hôpital Privé Paul d'Egine

    Champigny-sur-Marne, 94500
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.